GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
A former US Army colonel received two-year prison sentence for sharing a top-secret war plan with a woman he met online...
Pima County Sheriff Chris Nanos fired back on claims that he withheld essential physical evidence from the FBI in the disappearance of Nancy Guthrie....
Minnesota Gov. Tim Walz proposes $10 million emergency relief for small businesses impacted by Trump administration's immigration crackdown, stirring up Republican criticism of "new avenue for fraud."...
